Dr. Agarwal's Eye [DRAGARWQ] vs Apollo Hospitals [APOLLOHOSP] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Dr. Agarwal's Eye Hospital Ltd. wins in 12 metrics, Apollo Hospitals Enterprise Ltd. wins in 8 metrics, with 0 ties. Dr. Agarwal's Eye Hospital Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dr. Agarwal's Eye Hospital Ltd. | Apollo Hospitals Enterprise Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.01 | 61.08 | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Book Ratio | 7.52 | 12.11 | Dr. Agarwal's Eye Hospital Ltd. |
| Debt-to-Equity Ratio | 106.45 | 83.61 | Apollo Hospitals Enterprise Ltd. |
| PEG Ratio | 1.81 | 1.87 | Dr. Agarwal's Eye Hospital Ltd. |
| EV/EBITDA | 20.64 | 35.93 | Dr. Agarwal's Eye Hospital Ltd. |
| Profit Margin (TTM) | 15.50% | 7.44% | Dr. Agarwal's Eye Hospital Ltd. |
| Operating Margin (TTM) | 19.54% | 11.52% | Dr. Agarwal's Eye Hospital Ltd. |
| EBITDA Margin (TTM) | 19.54% | 11.52% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Equity | 26.07% | 16.71% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Assets (TTM) | 8.91% | 7.00% | Dr. Agarwal's Eye Hospital Ltd. |
| Free Cash Flow (TTM) | $-83.80M | $4.24B | Apollo Hospitals Enterprise Ltd. |
| Dividend Yield | 0.11% | 0.26% | Apollo Hospitals Enterprise Ltd. |
| 1-Year Return | 12.35% | 21.50% | Apollo Hospitals Enterprise Ltd. |
| Price-to-Sales Ratio (TTM) | 5.39 | 4.55 | Apollo Hospitals Enterprise Ltd. |
| Enterprise Value | $26.69B | $1,154.53B | Apollo Hospitals Enterprise Ltd. |
| EV/Revenue Ratio | 5.92 | 4.77 | Apollo Hospitals Enterprise Ltd. |
| Gross Profit Margin (TTM) | 78.09% | 47.78% | Dr. Agarwal's Eye Hospital Ltd. |
| Revenue per Share (TTM) | $952 | $1,684 | Apollo Hospitals Enterprise Ltd. |
| Earnings per Share (Diluted) | $147.68 | $125.45 | Dr. Agarwal's Eye Hospital Ltd. |
| Beta (Stock Volatility) | -0.57 | 0.18 | Dr. Agarwal's Eye Hospital Ltd. |
Dr. Agarwal's Eye Hospital Ltd. vs Apollo Hospitals Enterprise Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye Hospital Ltd. | 0.58% | 0.12% | -1.62% | 6.94% | -8.52% | -6.31% |
| Apollo Hospitals Enterprise Ltd. | -0.33% | 1.38% | 4.79% | 13.08% | 19.52% | 19.10% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye Hospital Ltd. | 12.35% | 240.02% | 1,131.89% | 2,480.68% | 5,282.48% | 17,498.05% |
| Apollo Hospitals Enterprise Ltd. | 21.50% | 63.42% | 163.79% | 556.24% | 1,658.87% | 4,106.51% |
Performance & Financial Health Analysis: Dr. Agarwal's Eye Hospital Ltd. vs Apollo Hospitals Enterprise Ltd.
| Metric | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹24.28B | ₹1.12T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 1,256 | 402,584 |
| 90 Day Avg. Volume | 1,378 | 434,868 |
| Last Close | ₹4,991.20 | ₹8,470.00 |
| 52 Week Range | ₹4,142.00 - ₹6,392.00 | ₹6,696.50 - ₹8,624.00 |
| % from 52W High | -21.91% | -1.79% |
| All-Time High | ₹7,300.00 (Dec 30, 2024) | ₹552,030.00 (Nov 20, 2023) |
| % from All-Time High | -31.63% | -98.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.22% | 0.17% |
| Quarterly Earnings Growth | 0.66% | 0.35% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | 0.07% |
| Operating Margin (TTM) | 0.20% | 0.12% |
| Return on Equity (TTM) | 0.26% | 0.17% |
| Debt to Equity (MRQ) | 106.45 | 83.61 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹668.22 | ₹632.45 |
| Cash per Share (MRQ) | ₹191.98 | ₹218.70 |
| Operating Cash Flow (TTM) | ₹738.70M | ₹14.57B |
| Levered Free Cash Flow (TTM) | ₹546.50M | ₹14.46B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.11% | 0.26% |
| Last 12-Month Dividend | ₹5.00 | ₹20.00 |
Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye Hospital Ltd. vs Apollo Hospitals Enterprise Ltd.
| Metric | DRAGARWQ (Apr 26, 2026) | APOLLOHOSP (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.01 | 61.08 |
| Forward P/E | 516.77 | 46.07 |
| PEG Ratio | 1.81 | 1.87 |
| Price to Sales (TTM) | 5.39 | 4.55 |
| Price to Book (MRQ) | 7.52 | 12.11 |
| Market Capitalization | ||
| Market Capitalization | ₹24.28B | ₹1.12T |
| Enterprise Value | ₹26.69B | ₹1.15T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.92 | 4.77 |
| Enterprise to EBITDA | 20.64 | 35.93 |
| Risk & Other Metrics | ||
| Beta | -0.57 | 0.18 |
| Book Value per Share (MRQ) | ₹668.22 | ₹632.45 |
Financial Statements Comparison: Dr. Agarwal's Eye Hospital Ltd. vs Apollo Hospitals Enterprise Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DRAGARWQ (2025) | APOLLOHOSP (2025) |
|---|---|---|
| Revenue/Sales | 3.94B | 215.77B |
| Cost of Goods Sold | 896.20M | 113.10B |
| COGS % of Revenue | 22.8% | 52.4% |
| Gross Profit | 3.04B | 102.67B |
| Gross Margin | 77.2% | 47.6% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 813.30M | 22.76B |
| Operating Margin | 20.6% | 10.5% |
| EBITDA | 1.22B | 31.48B |
| EBITDA Margin | 31.1% | 14.6% |
| Pre-Tax Income | 707.00M | 20.39B |
| Pre-Tax Income % of Revenue | 17.9% | 9.5% |
| Income Tax | 160.50M | 5.34B |
| Income Tax % of Revenue | 4.1% | 2.5% |
| Net Income (Profit) | 546.50M | 15.05B |
| Profit Margin | 13.9% | 7.0% |
Balance Sheet & Liquidity Metrics
| Metric | DRAGARWQ (2025) | APOLLOHOSP (2025) |
|---|---|---|
| Cash & Equivalents | 111.60M | 5.78B |
| Total Current Assets | 559.40M | 70.29B |
| Total Current Assets % of Revenue | 14.2% | 32.6% |
| Total Current Liabilities | 869.80M | 45.79B |
| Total Current Liabilities % of Revenue | 22.1% | 21.2% |
| Long-Term Debt | 3.06B | 43.86B |
| Long-Term Debt % of Revenue | 77.6% | 20.3% |
| Total Shareholders Equity | 2.10B | 86.53B |
| Retained Earnings | 1.99B | 39.41B |
| Retained Earnings % of Revenue | 50.4% | 18.3% |
| Property, Plant & Equipment | 1.37B | 39.33B |
Cash Flow Statement Comparison
| Metric | DRAGARWQ (2025) | APOLLOHOSP (2025) |
|---|---|---|
| Operating Cash Flow | 738.70M | 14.57B |
| Operating Cash Flow % of Revenue | 18.8% | 6.8% |
| Capital Expenditures | 4.10M | -16.98B |
| Free Cash Flow | -83.80M | 4.24B |
| FCF Margin | -2.1% | 2.0% |
| Debt Repayment | -111.30M | -4.42B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 4.83M | 143.78M |
| Float Shares | 1.08M | 100.66M |
| % Held by Insiders | 77.59% | 28.02% |
| % Held by Institutions | 3.57% | 47.21% |
| % Held by Public | 18.84% | 24.77% |
Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye Hospital Ltd. vs Apollo Hospitals Enterprise Ltd.
| Metric | DRAGARWQ | APOLLOHOSP |
|---|---|---|
| Last 12-Month Dividend | ₹5.00 | ₹20.00 |
| Last 12-Month Dividend Yield | 0.11% | 0.26% |
| 3-Year Avg Annual Dividend | ₹4.50 | ₹23.00 |
| 3-Year Avg Dividend Yield | 0.12% | 0.14% |
| 3-Year Total Dividends | ₹13.50 | ₹69.00 |
| Ex-Dividend Date | Nov 08, 2024 | Feb 16, 2026 |